
|Articles|September 1, 2001
Interferon alfa-2b appears to lesson chances of recurrence
Intermediate dosing of agent may enhance distant metastatis-free intervalfor high-risk patients
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
5











